Immunovaccine raises C$10M in bought deal

On May 31, immunotherapy company Immunovaccine Inc. (TSX:IMV; OTCQX:IMMVF) raised C$10 million ($7.4 million) through the sale of 7.7 million shares at C$1.30 in a bought deal underwritten by Echelon ...